CORALABPharmaceuticals
Coral Laboratories Ltd — Balance Sheet
₹370.55
-4.99%
Coral Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.36 Cr | 0.36 Cr | 0.36 Cr | 0.36 Cr | — |
| Share Issued | 0.36 Cr | 0.36 Cr | 0.36 Cr | 0.36 Cr | — |
| Net Debt | 0.15 Cr | — | — | 3.53 Cr | 3.93 Cr |
| Total Debt | 3.56 Cr | 0.00 | 0.00 | 6.04 Cr | — |
| Tangible Book Value | 201.14 Cr | 177.43 Cr | 154.78 Cr | 156.03 Cr | — |
| Invested Capital | 204.76 Cr | 177.50 Cr | 154.80 Cr | 162.09 Cr | — |
| Working Capital | 151.59 Cr | 128.96 Cr | 111.68 Cr | 105.29 Cr | — |
| Net Tangible Assets | 201.14 Cr | 177.43 Cr | 154.78 Cr | 156.03 Cr | — |
| Common Stock Equity | 201.21 Cr | 177.50 Cr | 154.80 Cr | 156.05 Cr | — |
| Total Capitalization | 201.21 Cr | 177.50 Cr | 154.80 Cr | 156.05 Cr | — |
| Total Equity Gross Minority Interest | 201.21 Cr | 177.50 Cr | 154.80 Cr | 156.05 Cr | — |
| Stockholders Equity | 201.21 Cr | 177.50 Cr | 154.80 Cr | 156.05 Cr | — |
| Other Equity Interest | 197.63 Cr | 173.92 Cr | — | 152.48 Cr | 133.07 Cr |
| Capital Stock | 3.57 Cr | 3.57 Cr | 3.57 Cr | 3.57 Cr | — |
| Common Stock | 3.57 Cr | 3.57 Cr | 3.57 Cr | 3.57 Cr | — |
| Total Liabilities Net Minority Interest | 28.26 Cr | 28.18 Cr | 19.55 Cr | 33.84 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 3.30 Cr | 3.28 Cr | 7.69 Cr | 8.33 Cr | — |
| Other Non Current Liabilities | -1000.00 | — | — | 2000.00 | 0.21 Cr |
| Non Current Deferred Taxes Liabilities | 2.55 Cr | 2.57 Cr | 2.54 Cr | 2.58 Cr | — |
| Long Term Debt And Capital Lease Obligation | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Provisions | 0.41 Cr | 0.39 Cr | 4.83 Cr | 4.83 Cr | — |
| Current Liabilities | 24.96 Cr | 24.90 Cr | 11.86 Cr | 25.52 Cr | — |
| Other Current Liabilities | 4.74 Cr | 0.27 Cr | 0.07 Cr | 0.15 Cr | — |
| Current Debt And Capital Lease Obligation | 3.56 Cr | 0.00 | 0.00 | 6.04 Cr | — |
| Current Debt | 3.56 Cr | 0.00 | 0.00 | 6.04 Cr | — |
| Current Provisions | 1.70 Cr | 0.63 Cr | 1.19 Cr | 0.64 Cr | — |
| Payables | 14.95 Cr | 18.35 Cr | 8.10 Cr | 15.21 Cr | — |
| Total Tax Payable | 8.33 Cr | 4.91 Cr | 1.82 Cr | 2.75 Cr | — |
| Accounts Payable | 6.62 Cr | 13.24 Cr | 4.21 Cr | 8.80 Cr | — |
| Total Assets | 229.46 Cr | 205.68 Cr | 174.35 Cr | 189.90 Cr | — |
| Total Non Current Assets | 52.92 Cr | 51.83 Cr | 50.81 Cr | 59.09 Cr | — |
| Other Non Current Assets | 0.73 Cr | 1.06 Cr | 1000.00 | -1000.00 | — |
| Non Current Deferred Taxes Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investmentin Financial Assets | 26.63 Cr | 24.04 Cr | 17.41 Cr | 24.43 Cr | — |
| Available For Sale Securities | 26.63 Cr | 24.04 Cr | 17.41 Cr | 24.43 Cr | — |
| Investment Properties | 0.92 Cr | 0.94 Cr | 0.96 Cr | 0.99 Cr | — |
| Goodwill And Other Intangible Assets | 0.07 Cr | 0.06 Cr | 0.02 Cr | 0.02 Cr | — |
| Net PPE | 24.23 Cr | 23.30 Cr | 24.28 Cr | 24.49 Cr | — |
| Gross PPE | 24.23 Cr | 49.92 Cr | 49.10 Cr | 47.24 Cr | — |
| Construction In Progress | 2.48 Cr | 0.02 Cr | 0.00 | 1.72 Cr | — |
| Other Properties | 21.74 Cr | 23.27 Cr | 24.28 Cr | 22.77 Cr | — |
| Current Assets | 176.54 Cr | 153.85 Cr | 123.54 Cr | 130.80 Cr | — |
| Other Current Assets | 18.83 Cr | 1000.00 | 21.12 Cr | 1000.00 | — |
| Inventory | 9.87 Cr | 15.16 Cr | 12.50 Cr | 18.36 Cr | — |
| Other Receivables | 0.23 Cr | 0.20 Cr | 0.20 Cr | 0.16 Cr | — |
| Taxes Receivable | 6.56 Cr | 4.91 Cr | 2.00 Cr | 2.75 Cr | — |
| Accounts Receivable | 33.64 Cr | 28.19 Cr | 23.42 Cr | 38.11 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 107.41 Cr | 27.79 Cr | 30.01 Cr | 24.27 Cr | — |
| Other Short Term Investments | 104.00 Cr | 25.72 Cr | 23.88 Cr | 21.76 Cr | — |
| Cash And Cash Equivalents | 3.41 Cr | 2.07 Cr | 6.13 Cr | 2.51 Cr | — |
| Retained Earnings | — | 147.46 Cr | 131.67 Cr | 125.23 Cr | 116.18 Cr |
| Non Current Deferred Revenue | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Deferred Taxes Liabilities | — | 4.91 Cr | 1.82 Cr | 2.75 Cr | 2.58 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.73 Cr | 0.68 Cr | 0.72 Cr | 1.08 Cr |
| Dividends Payable | — | 5.11 Cr | 3.89 Cr | 6.41 Cr | 2.60 Cr |
| Non Current Prepaid Assets | — | 3.14 Cr | 7.78 Cr | 8.82 Cr | 2.53 Cr |
| Other Intangible Assets | — | 0.06 Cr | 0.02 Cr | 0.02 Cr | 0.03 Cr |
| Accumulated Depreciation | — | -26.63 Cr | -24.82 Cr | -22.75 Cr | -20.79 Cr |
| Machinery Furniture Equipment | — | 36.28 Cr | 35.50 Cr | 33.20 Cr | 28.93 Cr |
| Buildings And Improvements | — | 13.62 Cr | 13.60 Cr | 12.32 Cr | 12.27 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 59.36 Cr | 34.43 Cr | 35.16 Cr | 32.72 Cr |
| Prepaid Assets | — | 23.16 Cr | 22.98 Cr | 14.74 Cr | 12.99 Cr |
| Other Inventories | — | 2.96 Cr | 2.84 Cr | 3.45 Cr | 3.46 Cr |
| Finished Goods | — | 2.78 Cr | 1.98 Cr | 4.88 Cr | 5.61 Cr |
| Work In Process | — | 3.18 Cr | 0.85 Cr | 1.58 Cr | 1.57 Cr |
| Raw Materials | — | 6.24 Cr | 6.83 Cr | 8.45 Cr | 11.04 Cr |
| Allowance For Doubtful Accounts Receivable | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Accounts Receivable | — | 28.19 Cr | 23.42 Cr | 38.11 Cr | 39.16 Cr |
| Cash Financial | — | 2.07 Cr | 6.13 Cr | 2.51 Cr | 2.32 Cr |
| Tradeand Other Payables Non Current | — | — | 4.83 Cr | 0.53 Cr | 0.12 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | — | — | — | 36000.00 |
| Other Payable | — | — | — | — | 0.07 Cr |
| Trading Securities | — | — | — | — | 18.99 Cr |
| Long Term Equity Investment | — | — | — | — | 14.10 Cr |
| Investmentsin Associatesat Cost | — | — | — | — | 14.10 Cr |
| Land And Improvements | — | — | — | — | 0.92 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Coral Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.